Inflammation  >>  Januvia (sitagliptin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Januvia (sitagliptin) / Merck (MSD)
NCT02536248: Sitagliptin Therapy and Kinetics of Inflammatory Markers

Completed
3
20
Canada
Sitagliptin, Januvia, Placebo
Laval University, Merck Sharp & Dohme LLC
Type 2 Diabetes Mellitus
09/17
10/17

Download Options